Vivo Capital, LLC Chinook Therapeutics, Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$18.66 - $38.58 $1.17 Million - $2.42 Million
62,728 Added 7.19%
934,879 $35.9 Million
Q2 2021

Aug 16, 2021
SELL
$13.6 - $18.98 $4.54 Million - $6.34 Million
-334,115 Reduced 27.7%
872,151 $12.3 Million
Q4 2020

Feb 16, 2021
BUY
$11.9 - $20.91 $14.4 Million - $25.2 Million
1,206,266 New
1,206,266 $19.1 Million

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email